Comparison of levofloxacin versus clarithromycin efficacytherapy for helicobacter pylori eradicatio

Not Applicable

• Conditions: Helicobacter pylori.; Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters; B98.0

• Registration Number: IRCT20190606043826N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 194

Inclusion Criteria

Positive h.pylori people have indications of treatment
Age between 14 and 70 years
Patients with informed consent to participate in the study

Exclusion Criteria

Do not use the correct and regular drug
Incidence of unbearable side effects
Pregnancy and lactation
The presence of chronic liver, kidney and gastrointestinal diseases simultaneously
Previous history of h.pylori treatment in a recent month

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The presence or absence of stool antigen,. Timepoint: At the end of the first and second weeks of treatment. Method of measurement: Fecal antigen test to confirm eradication of infection.;Incidence or absence of drug side effects. Timepoint: At the end of the first and second weeks of treatment. Method of measurement: questionnaire.